URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


Patient-to-Patient Supply for Cell Immunotherapies Summit


Date
Oct 29, 2021 - 09:00 AM - Oct 30, 09:00 AM
Organizer
Hanson Wade
Venue
online
Location
Online,

Online,
Online,
US,
ZIP: 00000
Phone: +16174554188

Ticket Price: Conference Only (Industry Digital Pricing): USD 1699.0, Conference Only (Academic Digital Pricing): USD 1299.0, Conference Only (Standard Digital Pricing): USD 2199.0


- Implement robust, patient-centric supply chains for clinical to commercial readiness
- Optimize patient care with best practice guidelines and integrated platforms
- Maintain product quality at scale for seamless delivery of autologous and allogeneic therapies

As an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment, cell therapies pose unique supply chain challenges.

At the inaugural Patient-to-Patient Supply for Cell Immunotherapies Summit, this community will share their expertise and propose best practice for seamless vein-to-vein delivery at the clinical and commercial scale.

From time and temperature sensitivity, to patient-facing service and integrated platforms, a seamless vein-to-vein supply chain is central in maintaining cell immunotherapy safety and efficacy at scale and maximizing the patient experience.

Join the strategic experts from GSK, bluebird bio, Adaptimmune, Celgene, BMS and more, to discuss best practice for patient-facing supply chains and build integrated platforms for chain of identity and end-user access.

Early booking and academic discounts available - see the website for more details.

https://supply-cell-immunotherapy.com/

Contact:
[email protected]
+1 617 455 4188

URLs:
Tickets: https://go.evvnt.com/653704-2?pid=1052
Brochure: https://go.evvnt.com/653704-3?pid=1052


Speaker Details


Albert Ribickas, Supervisor, Cell Therapy Facility, Moffitt Cancer Center, Alexandra Gomez, Associate Director Patient Services Operations, bluebird bio, Amol Thote, Senior Director Cell and Gene Therapy Network Strategy and Supply Chain Management, Bayer, Anthony Colenburg, Director of Quality, Adicet Bio, Inc, Ben Wang, Executive Director of the Georgia Tech Manufacturing Institute, Georgia Institute of Technology, Bob Amareld, Head of Supply Chain, Precision Biosciences, Chelsea White, Schneider National Chair in Transportation and Logistics, Georgia Institute of Technology, Christopher Baldwin, Supply Chain Director, Cell and Gene Therapy, GSK, David Boodey, Supply Chain Manager, Adaptimmune Therapeutics, Debra Susarchick, Chief Product Officer, TrakCel, Devin Blass, Senior Director of Manufacturing and Supply Chain, Talaris Therapeutics, Emilie Gauthy, Industrialization Manager, Celyad, George O'Sullivan, Head of Supply Chain, Elevate Bio, Gregory Russotti, Chief Technology Officer, Century Therapeutics LLC., Jean Stanton, Director Commercial Apheresis Operations, The Janssen Pharmaceutical Companies of Johnson and Johnson, Kawa Chiu, Vice President of CMC Supply Chain, Lyell Immunopharma, Kirstin Powel, Global Head, External Quality Operations, Novartis Cell and Gene Therapy, Nan Zhang, GMP Cellular Therapy Lead, Children's National Health System, Neeraj Shah, Global Clinical Supply Chain Excellence, Bristol-Myers Squibb, Reggie Foster, Sr. Director of Labelling, Logistics, and Packaging, Kite: A Gilead Company, Richard McFarland, President, Standards Coordinating Body, Shah Ahmad, Associate Director Cell Therapy External Manufacturing and Strategic Sourcing, Celgene, Sheng Lin-Gibson, Chief, NIST Biosystems and Biomaterials Division, Vadim Klyushnichenko, VP, Pharmaceutical Development and Quality, Cailbr at Scripps Research, William Shingler, Senior Director, Patient and Cell Management, Autolus Ltd

Event Categories
Keywords: pharmaceutical , Medicine




Comments








Events Calendar

SunMonTueWedThuFriSat
26 27 28 29 30 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99